Vaxcyte Inc (NAS:PCVX)
$ 102.7 -1.37 (-1.32%) Market Cap: 12.80 Bil Enterprise Value: 10.82 Bil PE Ratio: 0 PB Ratio: 3.79 GF Score: 40/100

Vaxcyte Inc at Needham Healthcare Conference (Virtual) Transcript

Apr 12, 2022 / 04:45PM GMT
Release Date Price: $24.95 (+0.65%)
Joseph Robert Stringer
Needham & Company, LLC, Research Division - Senior Analyst

Good afternoon, everyone. Thank you for joining the 21st Annual Needham Healthcare Conference. My name is Joey Stringer, and I'm one of the biotech analysts at Needham & Company. It's my pleasure to introduce our next presenting company, Vaxcyte. Joining us today from Vaxcyte is CEO, Grant Pickering; and COO, Jim Wassil. (Operator Instructions)

With that, we'll get started. I'll turn it over to Grant for some opening remarks, and then we'll start the chat.

Grant E. Pickering
Vaxcyte, Inc. - Co-Founder, CEO & Director

Great. Thank you, Joey. Delighted to be participating in the Needham conference. We really appreciate you including us. And I guess I'll just start out by saying I'm expecting that we'll be making some forward-looking statements over the course of this conversation and would direct you to the sec.gov page for our filings so you can have a more complete and balanced perspective on our business. And would just like to say that 2022 is going to be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot